Immunology studies in non-human primate models of tuberculosis

被引:112
作者
Flynn, JoAnne L. [1 ]
Gideon, Hannah P. [1 ]
Mattila, Joshua T. [1 ]
Lin, PhilanaLing [2 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp, Pittsburgh, PA 15213 USA
关键词
tuberculosis; immunology; non-human primate; macaque; granuloma; lymph node; TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; IMMUNE-RESPONSE; CYNOMOLGUS MACAQUES; CD8(+) T; ANIMAL-MODELS; FACTOR-ALPHA;
D O I
10.1111/imr.12258
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Non-human primates, primarily macaques, have been used to study tuberculosis for decades. However, in the last 15years, this model has been refined substantially to allow careful investigations of the immune response and host-pathogen interactions in Mycobacterium tuberculosis infection. Low-dose challenge with fully virulent strains in cynomolgus macaques result in the full clinical spectrum seen in humans, including latent and active infection. Reagents from humans are usually cross-reactive with macaques, further facilitating the use of this model system to study tuberculosis. Finally, macaques develop the spectrum of granuloma types seen in humans, providing a unique opportunity to investigate bacterial and host factors at the local (lung and lymph node) level. Here, we review the past decade of immunology and pathology studies in macaque models of tuberculosis.
引用
收藏
页码:60 / 73
页数:14
相关论文
共 100 条
[1]  
Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994
[2]  
[Anonymous], TUBERCULOSIS EDINB
[3]   Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials [J].
Arbues, Ainhoa ;
Aguilo, Juan I. ;
Gonzalo-Asensio, Jesus ;
Marinova, Dessislava ;
Uranga, Santiago ;
Puentes, Eugenia ;
Fernandez, Conchita ;
Parra, Alberto ;
Cardona, Pere Joan ;
Vilaplana, Cristina ;
Ausina, Vicente ;
Williams, Ann ;
Clark, Simon ;
Malaga, Wladimir ;
Guilhot, Christophe ;
Gicquel, Brigitte ;
Martin, Carlos .
VACCINE, 2013, 31 (42) :4867-4873
[4]   Elevated levels of α-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis [J].
Ashitani, J ;
Mukae, H ;
Hiratsuka, T ;
Nakazato, M ;
Kumamoto, K ;
Matsukura, S .
CHEST, 2002, 121 (02) :519-526
[5]   CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition [J].
Barber, Daniel L. ;
Mayer-Barber, Katrin D. ;
Feng, Carl G. ;
Sharpe, Arlene H. ;
Sher, Alan .
JOURNAL OF IMMUNOLOGY, 2011, 186 (03) :1598-1607
[6]   The spectrum of latent tuberculosis: rethinking the biology and intervention strategies [J].
Barry, Clifton E., III ;
Boshoff, Helena I. ;
Dartois, Veronique ;
Dick, Thomas ;
Ehrt, Sabine ;
Flynn, JoAnne ;
Schnappinger, Dirk ;
Wilkinson, Robert J. ;
Young, Douglas .
NATURE REVIEWS MICROBIOLOGY, 2009, 7 (12) :845-855
[7]   Is tuberculosis a lymphatic disease with a pulmonary portal? [J].
Behr, Marcel A. ;
Waters, W. Ray .
LANCET INFECTIOUS DISEASES, 2014, 14 (03) :250-255
[8]   Macrophage polarization in bacterial infections [J].
Benoit, Marie ;
Desnues, Benoit ;
Mege, Jean-Louis .
JOURNAL OF IMMUNOLOGY, 2008, 181 (06) :3733-3739
[9]   An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis [J].
Berry, Matthew P. R. ;
Graham, Christine M. ;
McNab, Finlay W. ;
Xu, Zhaohui ;
Bloch, Susannah A. A. ;
Oni, Tolu ;
Wilkinson, Katalin A. ;
Banchereau, Romain ;
Skinner, Jason ;
Wilkinson, Robert J. ;
Quinn, Charles ;
Blankenship, Derek ;
Dhawan, Ranju ;
Cush, John J. ;
Mejias, Asuncion ;
Ramilo, Octavio ;
Kon, Onn M. ;
Pascual, Virginia ;
Banchereau, Jacques ;
Chaussabel, Damien ;
O'Garra, Anne .
NATURE, 2010, 466 (7309) :973-U98
[10]   Cutting edge: A new approach to modeling early lung immunity in murine tuberculosis [J].
Bhatt, K ;
Hickman, SP ;
Salgame, P .
JOURNAL OF IMMUNOLOGY, 2004, 172 (05) :2748-2751